These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4380483)

  • 1. Spectrum analysis of electroencephalographic changes induced by some psychoactive agents. Their possible relationship to changes in cerebral biogenic amine levels.
    Eidelberg E; Miller MK; Long M
    Int J Neuropharmacol; 1966 Jan; 5(1):59-74. PubMed ID: 4380483
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of manipulation of biogenic amine levels upon spinal cord reflexes.
    Wooley DF
    Proc West Pharmacol Soc; 1968; 11():65-7. PubMed ID: 4390202
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of biogenic amines in memory formation.
    Dismukes RK; Rake AV
    Psychopharmacologia; 1972; 23(1):17-25. PubMed ID: 4259732
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 6. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 7. Central effects of 3,4-dihydroxyphenylalanine and 5-hydroxytryptophane on tetrabenazine pretreated rabbits with special reference to the possible role of catecholamine and serotonin in the brain.
    Takagi H; Satoh M; Yamatsu K; Kimura K; Nakama M
    Int J Neuropharmacol; 1968 May; 7(3):265-73. PubMed ID: 5305181
    [No Abstract]   [Full Text] [Related]  

  • 8. On the relationship between drug-induced changes in brain amines and body temperature.
    Ingenito AJ; Bonnycastle DD
    Can J Physiol Pharmacol; 1967 Jul; 45(4):723-32. PubMed ID: 5298528
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental findings and new aspects in extrapyramidal diseases].
    Birkmayer W
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):128-39. PubMed ID: 4226878
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of biogenic amines in the effects of marijuana on EEG patterns in cats.
    Adams PM; Barratt ES
    Electroencephalogr Clin Neurophysiol; 1975 Dec; 39(6):621-5. PubMed ID: 53140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to norepinephrine and serotonin metabolism in the rat brain following stress conditions].
    Rüther E; Ackenheil M; Matussek N
    Arzneimittelforschung; 1966 Feb; 16(2):261-3. PubMed ID: 5299190
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 16. Opposite effect of harmaline on seotonin and on dopamine and its metabolites, homovanillic acid and norepinephrine, in the brain of the cat.
    Poirier LJ; Singh P; Boucher R
    Can J Physiol Pharmacol; 1968 Jul; 46(4):585-9. PubMed ID: 5302163
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for a direct action of monamines on the chick central nervous system.
    Spooner CE; Winters WD
    Experientia; 1965 May; 21(5):256-8. PubMed ID: 5294557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sleep and monoamines].
    Jouvet M
    Bull Schweiz Akad Med Wiss; 1966 Dec; 22(4):287-305. PubMed ID: 5300838
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.